Patent | Date |
---|
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide App 20190119365 - Baurin; Nicolas ;   et al. | 2019-04-25 |
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide Grant 10,112,991 - Baurin , et al. October 30, 2 | 2018-10-30 |
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide App 20160368977 - Baurin; Nicolas ;   et al. | 2016-12-22 |
Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease App 20160354445 - HESS; Sibylle ;   et al. | 2016-12-08 |
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide Grant 9,382,312 - Baurin , et al. July 5, 2 | 2016-07-05 |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease Grant 9,364,519 - Hess , et al. June 14, 2 | 2016-06-14 |
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide App 20140105890 - BAURIN; Nicolas ;   et al. | 2014-04-17 |
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide Grant 8,614,299 - Baurin , et al. December 24, 2 | 2013-12-24 |
Transgeneic animal expressing a multiple mutated form of presenilin 1 Grant 8,492,610 - Eckert , et al. July 23, 2 | 2013-07-23 |
Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease App 20130116179 - HESS; Sibylle ;   et al. | 2013-05-09 |
Antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs Grant 8,343,493 - VanMechelen , et al. January 1, 2 | 2013-01-01 |
Nucleic acids encoding a human PAP1 polypeptide Grant 8,273,548 - Koutnikova , et al. September 25, 2 | 2012-09-25 |
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide App 20120177639 - Baurin; Nicolas ;   et al. | 2012-07-12 |
Antibodies Specific Of The Beta-amyloid Peptides And Their Uses As Diagnostic Agents Or Drugs App 20110059092 - Vanmechelen; Eugeen ;   et al. | 2011-03-10 |
Method for detecting Alzheimer's disease Grant 7,803,538 - Mace , et al. September 28, 2 | 2010-09-28 |
Transgenic animals exhibiting major disorders related to Alzheimer's disease Grant 7,700,823 - Casas Louzao , et al. April 20, 2 | 2010-04-20 |
Compositions which can be used for regulating the activity of parkin App 20060287230 - Koutnikova; Hana ;   et al. | 2006-12-21 |
Compositions which can be used for regulating the activity of parkin Grant 7,132,396 - Koutnikova , et al. November 7, 2 | 2006-11-07 |
Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein Grant 7,070,940 - Corti , et al. July 4, 2 | 2006-07-04 |
Transgenic animals exhibiting major disorders related to Alzheimer's disease App 20050076400 - Casas Louzao, Caty ;   et al. | 2005-04-07 |
Method for detecting Alzheimer's disease App 20050003417 - Mace, Sandrine ;   et al. | 2005-01-06 |
Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF) App 20040224409 - Pradier, Laurent ;   et al. | 2004-11-11 |
Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein App 20040214763 - Corti, Olga ;   et al. | 2004-10-28 |
Application of intestinal biliary acid reuptake inhibitors for the prevention and treatment of alzheimer's disease App 20040138145 - Canton, Thierry ;   et al. | 2004-07-15 |
Interaction test for the investigation of inhibitory molecules of the interaction between a presenilin and the .beta.-amyloid peptide Grant 6,653,088 - Czech , et al. November 25, 2 | 2003-11-25 |
Compositions which can be used for regulating the activity of parkin App 20020155577 - Koutnikova, Hana ;   et al. | 2002-10-24 |